| 1 |
Xiao M, Zhong LLD, Lam WC, Zhao Y, Gwee KA, Holtmann G, Tack J, Suzuki H, Chen MH, Xiao Y, Hou X, Liu J, Li Y, Tang XD, Lu F. Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial. Trials 2022;23:454. [PMID: 35655286 DOI: 10.1186/s13063-022-06396-5] [Reference Citation Analysis]
|
| 2 |
Siriviriyakul P, Werawatganon D, Phetnoo N, Somanawat K, Chatsuwan T, Klaikeaw N, Chayanupatkul M. Genistein attenuated gastric inflammation and apoptosis in Helicobacter pylori-induced gastropathy in rats. BMC Gastroenterol 2020;20:410. [PMID: 33297977 DOI: 10.1186/s12876-020-01555-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 3 |
Azadbakht S, Azadbakht S, Esmaili A, Rahmani P. Comparison of clinical symptoms after Helicobacter pylori eradication in functional dyspepsia patients based on endoscopic view of antral gastropathy. New Microbes New Infect 2020;38:100806. [PMID: 33365132 DOI: 10.1016/j.nmni.2020.100806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Saito Y, Konno K, Sato M, Nakano M, Kato Y, Saito H, Serizawa H. Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori. Cancers (Basel) 2019;11:E116. [PMID: 30669474 DOI: 10.3390/cancers11010116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Suzuki H. New Medical Approach to Functional Dyspepsia, from Core Symposium 3, Japan Gastroenterological Association 2015-2017. Digestion 2018;97:6-12. [PMID: 29393229 DOI: 10.1159/000484029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 6 |
Nam K, Shin JE, Kim SE, Baik GH, Choi SH, Lee JY, Park KS, Joo YE, Myung DS, Kim HJ, Song HJ, Choi SC, Kim HJ, Kim HY, Kim N. Prevalence and risk factors for upper gastrointestinal diseases in health check-up subjects: a nationwide multicenter study in Korea. Scand J Gastroenterol 2018;53:910-6. [PMID: 30169983 DOI: 10.1080/00365521.2018.1487992] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 7 |
Ohishi T, Masuda T, Abe H, Hayashi C, Adachi H, Ohba SI, Igarashi M, Watanabe T, Mimuro H, Amalia E, Inaoka DK, Mochizuki K, Kita K, Shibasaki M, Kawada M. Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection. Helicobacter 2018;23:e12470. [PMID: 29488678 DOI: 10.1111/hel.12470] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 8 |
Liu J, Liu F, Shi Y, Tan H, Zhou L. Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database. FEBS Open Bio 2018;8:279-94. [PMID: 29435418 DOI: 10.1002/2211-5463.12365] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Scopel-Guerra A, Olivera-Severo D, Staniscuaski F, Uberti AF, Callai-Silva N, Jaeger N, Porto BN, Carlini CR. The Impact of Helicobacter pylori Urease upon Platelets and Consequent Contributions to Inflammation. Front Microbiol 2017;8:2447. [PMID: 29312166 DOI: 10.3389/fmicb.2017.02447] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 10 |
Geng X, Li W, Chen Z, Gao S, Hong W, Ge X, Hou G, Hu Z, Zhou Y, Zeng B, Li W, Jia J, Sun Y. The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. Antimicrob Agents Chemother 2017;61:e02011-16. [PMID: 28242673 DOI: 10.1128/AAC.02011-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 11 |
Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer 2017;20:3-7. [PMID: 27757699 DOI: 10.1007/s10120-016-0658-5] [Cited by in Crossref: 83] [Cited by in F6Publishing: 89] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 12 |
Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer. 2017;20:3-7. [PMID: 27757699 DOI: 10.1007/s10120-016-0685-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 13 |
UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-A720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 14 |
Ghalehnoei H, Ahmadzadeh A, Farzi N, Alebouyeh M, Aghdaei HA, Azimzadeh P, Molaei M, Zali MR. Relationship between ureB Sequence Diversity, Urease Activity and Genotypic Variations of Different Helicobacter pylori Strains in Patients with Gastric Disorders. Pol J Microbiol 2016;65:153-9. [PMID: 30015438 DOI: 10.5604/17331331.1204761] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 15 |
Sulzbach DE Oliveira HS, Biolchi V, Richardt Medeiros HR, Bizerra Gandor Jantsch DB, Knabben DE Oliveira Becker Delving LK, Reckziegel R, Goettert MI, Brum IS, Pozzobon A. Effect of Helicobacter pylori on NFKB1, p38α and TNF-α mRNA expression levels in human gastric mucosa. Exp Ther Med 2016;11:2365-72. [PMID: 27284322 DOI: 10.3892/etm.2016.3213] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 16 |
Yakoob J, Abbas Z, Jafri W, Khan R, Salim SA, Awan S, Abid S, Hamid S, Ahmad Z. Helicobacter pylori outer membrane protein and virulence marker differences in expatriate patients. Epidemiol Infect 2016;144:2200-8. [PMID: 26941114 DOI: 10.1017/S095026881600025X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 17 |
Kim N. Synopsis of H. pylori-Associated Diseases. Helicobacter pylori 2016. [DOI: 10.1007/978-981-287-706-2_16] [Reference Citation Analysis]
|
| 18 |
Kim SE. Functional Dyspepsia. Helicobacter pylori 2016. [DOI: 10.1007/978-981-287-706-2_18] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 19 |
Saito Y, Serizawa H, Kato Y, Nakano M, Nakamura M, Saito H, Suzuki H, Kanai T. First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype. World J Gastroenterol 2015; 21(48): 13548-13554 [PMID: 26730167 DOI: 10.3748/wjg.v21.i48.13548] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 20 |
Yakoob J, Abbas Z, Khan R, Salim SA, Awan S, Abrar A, Jafri W. Helicobacter pylori outer membrane protein Q allele distribution is associated with distinct pathologies in Pakistan. Infect Genet Evol 2016;37:57-62. [PMID: 26516025 DOI: 10.1016/j.meegid.2015.10.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 21 |
Xu Z, Yan A. Multidrug Efflux Systems in Microaerobic and Anaerobic Bacteria. Antibiotics (Basel) 2015;4:379-96. [PMID: 27025630 DOI: 10.3390/antibiotics4030379] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Tsugawa H, Mori H, Matsuzaki J, Masaoka T, Hirayama T, Nagasawa H, Sakakibara Y, Suematsu M, Suzuki H. Nordihydroguaiaretic Acid Disrupts the Antioxidant Ability of Helicobacter pylori through the Repression of SodB Activity In Vitro. Biomed Res Int 2015;2015:734548. [PMID: 25945343 DOI: 10.1155/2015/734548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 23 |
Iwakura N, Fujiwara Y, Tanaka F, Tanigawa T, Yamagami H, Shiba M, Tominaga K, Watanabe T, Iijima K, Koike T, Walls AF, Arakawa T. Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther 2015;41:776-84. [PMID: 25693747 DOI: 10.1111/apt.13141] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 24 |
Šešelja D, Straßer C. Heuristic reevaluation of the bacterial hypothesis of peptic ulcer disease in the 1950s. Acta Biotheor 2014;62:429-54. [PMID: 24986431 DOI: 10.1007/s10441-014-9219-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 25 |
Abdollahi A, Shoar S, Jafari S, Emadi-Kochak H. Seroprevalence of helicobacter pylori in human immunodeficiency virus-positive Patients and it's correlation with CD4(+) Lymphocyte Count. Niger Med J 2014;55:67-72. [PMID: 24970974 DOI: 10.4103/0300-1652.128176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 26 |
Masaoka T, Suzuki H. Do we need to eradicate Helicobacter pylori in patients with GORD? United European Gastroenterol J 2013;1:223-5. [PMID: 24917965 DOI: 10.1177/2050640613497713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 27 |
Wei Z, Ying L, Wen G, Mengnan Z, Yali Z. Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients. Helicobacter 2014;19:124-8. [PMID: 24617669 DOI: 10.1111/hel.12108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 28 |
Parra-cid T, Calvino-fernández M, Benito-martínez S, Pérez-gisbert J. Role of Reactive Oxygen Species and Apoptosis in Helicobacter pylori Infection. Systems Biology of Free Radicals and Antioxidants 2014. [DOI: 10.1007/978-3-642-30018-9_143] [Reference Citation Analysis]
|
| 29 |
Ishizuka N, Imazeki N, Senoo A, Sakurai J, Sonoda M, Kanazawa M, Suzuki Y, Kobayashi Y, Takahashi T, Haba R, Arai K, Shimizu H, Sasaki K, Kako M, Hayashi K, Suzuki Y, Inoue S. Cell proliferation in ventromedial hypothalamic lesioned rats inhibits acute gastric mucosal lesions. Obes Res Clin Pract 2012;6:e175-262. [PMID: 24331526 DOI: 10.1016/j.orcp.2011.12.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 30 |
Zaman C, Osaki T, Hanawa T, Yonezawa H, Kurata S, Kamiya S. Analysis of the microbial ecology between Helicobacter pylori and the gastric microbiota of Mongolian gerbils. J Med Microbiol 2014;63:129-37. [PMID: 24164959 DOI: 10.1099/jmm.0.061135-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 31 |
Watanabe A, Iwakiri R, Yamaguchi D, Higuchi T, Tsuruoka N, Miyahara K, Akutagawa K, Sakata Y, Fujise T, Oda Y, Shimoda R, Sakata H, Fujimoto K. Risk factors for resistance to proton pump inhibitor maintenance therapy for reflux esophagitis in Japanese women over 60 years. Digestion 2012;86:323-8. [PMID: 23128344 DOI: 10.1159/000342393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 32 |
Okanobu H, Ito M, Tanaka S, Onogawa S, Akagi M, Oh-E H, Nagata S, Okamoto S, Kuwai T, Cho S, Matsumoto Y, Kitamura S, Hidaka T, Chayama K. Evaluation of individual risk in nonvariceal gastrointestinal bleeding patients with NSAID administration: a multicenter study in Japan. Digestion 2012;86:187-93. [PMID: 22907391 DOI: 10.1159/000339710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 33 |
Takamura A, Ito M, Boda T, Matsumoto Y, Tanaka S, Yoshihara M, Chayama K. High expression of gastrin receptor protein in injured mucosa of Helicobacter pylori-positive gastritis. Dig Dis Sci 2013;58:634-40. [PMID: 23053898 DOI: 10.1007/s10620-012-2427-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013;10:168-74. [PMID: 23358394 DOI: 10.1038/nrgastro.2013.9] [Cited by in Crossref: 121] [Cited by in F6Publishing: 107] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 35 |
Uberti AF, Olivera-Severo D, Wassermann GE, Scopel-Guerra A, Moraes JA, Barcellos-de-Souza P, Barja-Fidalgo C, Carlini CR. Pro-inflammatory properties and neutrophil activation by Helicobacter pylori urease. Toxicon. 2013;69:240-249. [PMID: 23466444 DOI: 10.1016/j.toxicon.2013.02.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 36 |
Nakashita M, Suzuki H, Miura S, Taki T, Uehara K, Mizushima T, Nagata H, Hibi T. Attenuation of acetic acid-induced gastric ulcer formation in rats by glucosylceramide synthase inhibitors. Dig Dis Sci 2013;58:354-62. [PMID: 22918683 DOI: 10.1007/s10620-012-2350-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 37 |
Rajesh KP, Manjunatha H, Bharath BR. Simulated screening of flavonoids as probable anti-Helicobacter pylori drug. Med Chem Res 2013;22:4537-46. [DOI: 10.1007/s00044-012-0426-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 38 |
Saito Y, Suzuki H, Tsugawa H, Imaeda H, Matsuzaki J, Hirata K, Hosoe N, Nakamura M, Mukai M, Saito H, Hibi T. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One 2012;7:e47396. [PMID: 23209550 DOI: 10.1371/journal.pone.0047396] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 39 |
Saito Y, Suzuki H, Imaeda H, Matsuzaki J, Hirata K, Tsugawa H, Hibino S, Kanai Y, Saito H, Hibi T. The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. Int J Cancer. 2013;132:1751-1760. [PMID: 23001726 DOI: 10.1002/ijc.27862] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 40 |
Sakurai K, Nagahara A, Inoue K, Akiyama J, Mabe K, Suzuki J, Habu Y, Araki A, Suzuki T, Satoh K. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS). BMC Gastroenterol. 2012;12:42. [PMID: 22548767 DOI: 10.1186/1471-230x-12-42] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 41 |
Song KH, Lee YC, Fan DM, Ge ZZ, Ji F, Chen MH, Jung HC, Bo J, Lee SW, Kim JH. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study. Digestion 2011;84:221-9. [PMID: 21757914 DOI: 10.1159/000329353] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 42 |
Ito M, Yoshihara M, Takata S, Wada Y, Matsuo T, Boda T, Tanaka S, Chayama K. Serum screening for detection of high-risk group for early-stage diffuse type gastric cancer in Japanese. J Gastroenterol Hepatol 2012;27:598-602. [PMID: 21883453 DOI: 10.1111/j.1440-1746.2011.06893.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 43 |
Mogami S, Suzuki H, Fukuhara S, Matsuzaki J, Kangawa K, Hibi T. Reduced ghrelin production induced anorexia after rat gastric ischemia and reperfusion. Am J Physiol Gastrointest Liver Physiol 2012;302:G359-64. [PMID: 22114115 DOI: 10.1152/ajpgi.00297.2011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 44 |
Angrisano T, Lembo F, Peluso S, Keller S, Chiariotti L, Pero R. Helicobacter pylori regulates iNOS promoter by histone modifications in human gastric epithelial cells. Med Microbiol Immunol 2012;201:249-57. [DOI: 10.1007/s00430-011-0227-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 45 |
Gaynor D, Griffith DM. The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum. Dalton Trans 2012;41:13239. [DOI: 10.1039/c2dt31601c] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 46 |
Tsugawa H, Suzuki H, Matsuzaki J, Hirata K, Hibi T. FecA1, a bacterial iron transporter, determines the survival of Helicobacter pylori in the stomach. Free Radic Biol Med 2012;52:1003-10. [PMID: 22245091 DOI: 10.1016/j.freeradbiomed.2011.12.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 47 |
Shimpuku M, Futagami S, Kawagoe T, Nagoya H, Shindo T, Horie A, Kodaka Y, Itoh T, Sakamoto C. G-protein β3 subunit 825CC genotype is associated with postprandial distress syndrome with impaired gastric emptying and with the feeling of hunger in Japanese. Neurogastroenterol Motil 2011;23:1073-80. [PMID: 21902766 DOI: 10.1111/j.1365-2982.2011.01781.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 48 |
Suzuki H, Matsuzaki J, Hibi T. Metronidazole-based quadruple versus standard triple therapy: which is better as first-line therapy for Helicobacter pylori eradication? Expert Rev Clin Pharmacol 2011;4:579-82. [PMID: 22114887 DOI: 10.1586/ecp.11.34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 49 |
Suzuki H, Hibi T. Overlap syndrome of functional dyspepsia and irritable bowel syndrome - are both diseases mutually exclusive? J Neurogastroenterol Motil 2011;17:360-5. [PMID: 22148104 DOI: 10.5056/jnm.2011.17.4.360] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 50 |
Takamura A, Ito M, Imagawa S, Takata S, Tanaka S, Teixeira CR, Kamada T, Haruma K, Chayama K. Helicobacter pylori cagA polymorphism and gastric inflammation: an international comparison between Japanese and Brazilian patients. Scand J Gastroenterol 2011;46:1051-6. [PMID: 21736532 DOI: 10.3109/00365521.2011.598549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 51 |
Song KH, Yun M, Kim JH, Yang WI, Kang DR, Chung JB, Lee YC. Role of F-FDG PET Scans in Patients with Helicobacter pylori-Infected Gastric Low-Grade MALT Lymphoma. Gut Liver. 2011;5:308-314. [PMID: 21927659 DOI: 10.5009/gnl.2011.5.3.308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 52 |
Alves MK, Ferrasi AC, Lima VP, Ferreira MV, de Moura Campos Pardini MI, Rabenhorst SH. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype. Pathobiology. 2011;78:266-276. [PMID: 21849808 DOI: 10.1159/000329475] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 53 |
Suzuki H, Okada S, Hibi T. Proton-pump inhibitors for the treatment of functional dyspepsia. Therap Adv Gastroenterol 2011;4:219-26. [PMID: 21765866 DOI: 10.1177/1756283X11398735] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 54 |
Suzuki H, Matsuzaki J, Hibi T. What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J Neurogastroenterol Motil 2011;17:124-30. [PMID: 21602988 DOI: 10.5056/jnm.2011.17.2.124] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 55 |
Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Dig Dis Sci 2011;56:1131-7. [PMID: 20721625 DOI: 10.1007/s10620-010-1376-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 56 |
Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe gastric atrophy in Japanese. Dig Dis Sci 2011;56:1131-7. [PMID: 20721625 DOI: 10.1007/s10620-010-1376-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 57 |
Quach DT, Le HM, Nguyen OT, Nguyen TS, Uemura N. The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage. J Gastroenterol Hepatol 2011;26:281-5. [PMID: 21261717 DOI: 10.1111/j.1440-1746.2010.06474.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 58 |
Saito Y, Suzuki H, Tsugawa H, Suzuki S, Matsuzaki J, Hirata K, Hibi T. Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology 2011;140:189-98. [PMID: 20801118 DOI: 10.1053/j.gastro.2010.08.044] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 59 |
Tsugawa H, Suzuki H, Satoh K, Hirata K, Matsuzaki J, Saito Y, Suematsu M, Hibi T. Two amino acids mutation of ferric uptake regulator determines Helicobacter pylori resistance to metronidazole. Antioxid Redox Signal 2011;14:15-23. [PMID: 20518707 DOI: 10.1089/ars.2010.3146] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 60 |
Song HJ, Jang SJ, Yun SC, Park YS, Kim MJ, Lee SM, Choi KD, Lee GH, Jung HY, Kim JH. Low Levels of Pepsinogen I and Pepsinogen I/II Ratio are Valuable Serologic Markers for Predicting Extensive Gastric Corpus Atrophy in Patients Undergoing Endoscopic Mucosectomy. Gut Liver 2010;4:475-80. [PMID: 21253295 DOI: 10.5009/gnl.2010.4.4.475] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 61 |
Suzuki H, Saito Y, Hibi T. MicroRNAs in Gastric Cancer. In: Cho WC, editor. MicroRNAs in Cancer Translational Research. Dordrecht: Springer Netherlands; 2011. pp. 135-43. [DOI: 10.1007/978-94-007-0298-1_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 62 |
Tsugawa H, Suzuki H, Muraoka H, Ikeda F, Hirata K, Matsuzaki J, Saito Y, Hibi T. Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori. Biochem Biophys Res Commun 2011;404:656-60. [PMID: 21147064 DOI: 10.1016/j.bbrc.2010.12.034] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 63 |
Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer 2010;13:251-7. [PMID: 21128061 DOI: 10.1007/s10120-010-0567-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 64 |
Imagawa S, Ito M, Yoshihara M, Eguchi H, Tanaka S, Chayama K. Helicobacter pylori dupA and gastric acid secretion are negatively associated with gastric cancer development. J Med Microbiol. 2010;59:1484-1489. [PMID: 20829397 DOI: 10.1099/jmm.0.021816-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 65 |
Buzás GM. First-line eradication of Helicobacter pylori: Are the standard triple therapies obsolete? A different perspective. World J Gastroenterol 2010; 16(31): 3865-3870 [PMID: 20712046 DOI: 10.3748/wjg.v16.i31.3865] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 66 |
Ghoshal UC, Chourasia D. Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship? J Neurogastroenterol Motil. 2010;16:243-250. [PMID: 20680162 DOI: 10.5056/jnm.2010.16.3.243] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 67 |
Omatsu T, Naito Y, Handa O, Mizushima K, Hayashi N, Qin Y, Harusato A, Hirata I, Kishimoto E, Okada H, Uchiyama K, Ishikawa T, Takagi T, Yagi N, Kokura S, Ichikawa H, Yoshikawa T. Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury. J Gastroenterol 2010;45:692-702. [PMID: 20174833 DOI: 10.1007/s00535-010-0213-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 68 |
Sasaki M, Ogasawara N, Utsumi K, Kawamura N, Kamiya T, Kataoka H, Tanida S, Mizoshita T, Kasugai K, Joh T. Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin. J Clin Biochem Nutr. 2010;47:53-58. [PMID: 20664731 DOI: 10.3164/jcbn.10-10] [Cited by in Crossref: 65] [Cited by in F6Publishing: 73] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 69 |
Suzuki H, Nishizawa T, Hibi T. Helicobacter pylori eradication therapy. Future Microbiol. 2010;5:639-648. [PMID: 20353303 DOI: 10.2217/fmb.10.25] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 70 |
Suzuki H, Hibi T. Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia. Neurogastroenterol Motil 2010;22:595-9. [PMID: 20553562 DOI: 10.1111/j.1365-2982.2010.01486.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 71 |
Alves MK, Lima VP, Ferrasi AC, Rodrigues MA, De Moura Campos Pardini MI, Rabenhorst SH. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas. APMIS. 2010;118:297-307. [PMID: 20402675 DOI: 10.1111/j.1600-0463.2010.02591.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 72 |
Zaman C, Osaki T, Hanawa T, Yonezawa H, Kurata S, Kamiya S. Analysis of the microflora in the stomach of Mongolian gerbils infected with Helicobacter pylori. J Gastroenterol Hepatol 2010;25 Suppl 1:S11-4. [PMID: 20586850 DOI: 10.1111/j.1440-1746.2009.06215.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Suzuki S, Suzuki H, Horiguchi K, Tsugawa H, Matsuzaki J, Takagi T, Shimojima N, Hibi T. Delayed gastric emptying and disruption of the interstitial cells of Cajal network after gastric ischaemia and reperfusion. Neurogastroenterol Motil 2010;22:585-93, e126. [PMID: 20040059 DOI: 10.1111/j.1365-2982.2009.01444.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 74 |
Hirata K, Suzuki H, Nishizawa T, Tsugawa H, Muraoka H, Saito Y, Matsuzaki J, Hibi T. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J Gastroenterol Hepatol 2010;25 Suppl 1:S75-9. [PMID: 20586871 DOI: 10.1111/j.1440-1746.2009.06220.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 75 |
Matsuzaki J, Suzuki H, Tsugawa H, Nishizawa T, Hibi T. Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy. J Gastroenterol Hepatol 2010;25 Suppl 1:S7-10. [PMID: 20586870 DOI: 10.1111/j.1440-1746.2010.06245.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 76 |
Suzuki H, Matsuzaki J, Hibi T. Ghrelin and oxidative stress in gastrointestinal tract. J Clin Biochem Nutr. 2011;48:122-125. [PMID: 21373264 DOI: 10.3164/jcbn.10-16gfr] [Cited by in Crossref: 51] [Cited by in F6Publishing: 58] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 77 |
Makino Y, Suzuki H, Nishizawa T, Kameyama K, Hisamatsu T, Imaeda H, Mukai M, Hibi T. Ileal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with a Large-Cell Component That Regressed Spontaneously. Gut Liver. 2010;4:117-121. [PMID: 20479924 DOI: 10.5009/gnl.2010.4.1.117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 78 |
Ito M. Helicobacter pylori eradication for gastric cancer prevention. Expert Rev Anticancer Ther 2010;10:1-3. [PMID: 20014879 DOI: 10.1586/era.09.160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 79 |
Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, Wakai K, Tajima K, Hamajima N. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese. Gastric Cancer 2010;13:43-9. [PMID: 20373075 DOI: 10.1007/s10120-009-0534-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 80 |
Hishida A, Matsuo K, Goto Y, Mitsuda Y, Naito M, Wakai K, Tajima K, Hamajima N. Significant association of RUNX3 T/A polymorphism at intron 3 (rs760805) with the risk of gastric atrophy in Helicobacter pylori seropositive Japanese. J Gastroenterol 2009;44:1165-71. [PMID: 19728008 DOI: 10.1007/s00535-009-0118-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 81 |
Matsuzaki J, Suzuki H, Asakura K, Saito Y, Hirata K, Takebayashi T, Hibi T. Gallstones increase the prevalence of Barrett's esophagus. J Gastroenterol 2010;45:171-8. [PMID: 19908109 DOI: 10.1007/s00535-009-0153-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
Suzuki H. Post-infectious Functional Dyspepsia - A Novel Disease Entity among Functional Gastrointestinal Disorders - Relation to Helicobacter pylori Infection? (Neurogastroenterol Motil 2009;21:832-e56). J Neurogastroenterol Motil 2010;16:97-8. [PMID: 20535335 DOI: 10.5056/jnm.2010.16.1.97] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 83 |
Alpízar-Alpízar W, Nielsen BS, Sierra R, Illemann M, Ramírez JA, Arias A, Durán S, Skarstein A, Ovrebo K, Lund LR, Laerum OD. Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high- and low-risk countries. Int J Cancer 2010;126:405-15. [PMID: 19609941 DOI: 10.1002/ijc.24755] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 84 |
Kim KK, Kim HB. Protein interaction network related to Helicobacter pylori infection response. World J Gastroenterol. 2009;15:4518-4528. [PMID: 19777610 DOI: 10.3748//wjg.15.4518] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 85 |
Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Takahama K, Watanabe M, Hirata I, Arisawa T. MTHFR 677T carrier influences the methylation status of H. pylori-infected gastric mucosa in older subjects. Dig Dis Sci 2009;54:2391-8. [PMID: 19082889 DOI: 10.1007/s10620-008-0624-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 86 |
Kim KK, Kim HB. Protein interaction network related to Helicobacter pylori infection response. World J Gastroenterol 2009; 15(36): 4518-4528 [PMID: 19777610 DOI: 10.3748/wjg.15.4518] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 87 |
Wassermann GE, Olivera-Severo D, Uberti AF, Carlini CR. Helicobacter pylori urease activates blood platelets through a lipoxygenase-mediated pathway. J Cell Mol Med 2010;14:2025-34. [PMID: 19754669 DOI: 10.1111/j.1582-4934.2009.00901.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 88 |
Ono S, Kato M, Imai A, Yoshida T, Hirota J, Hata T, Takagi K, Kamada G, Ono Y, Nakagawa M. Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Biochem Nutr. 2009;45:248-253. [PMID: 19794936 DOI: 10.3164/jcbn.09-24] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 89 |
Suzuki H, Iwasaki E, Hibi T. Helicobacter pylori and gastric cancer. Gastric Cancer 2009;12:79-87. [PMID: 19562461 DOI: 10.1007/s10120-009-0507-x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 89] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 90 |
Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 2009;44:518-34. [PMID: 19365600 DOI: 10.1007/s00535-009-0047-5] [Cited by in Crossref: 234] [Cited by in F6Publishing: 223] [Article Influence: 16.7] [Reference Citation Analysis]
|
| 91 |
Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, Takamura A, Kitamura S, Matsuo T, Tanaka S, Haruma K, Chayama K. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol 2009;44:365-71. [PMID: 19333542 DOI: 10.1007/s00535-009-0036-8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 92 |
Takata S, Ito M, Wada Y, Yoshihara M, Tanaka S, Chayama K. Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients. J Gastroenterol 2009;44:405-11. [PMID: 19347242 DOI: 10.1007/s00535-009-0015-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 93 |
Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese. BMC Gastroenterol 2009;9:51. [PMID: 19589142 DOI: 10.1186/1471-230X-9-51] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 94 |
Suzuki H, Saito Y, Hibi T. Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis. Gut Liver. 2009;3:81-87. [PMID: 20431728 DOI: 10.5009/gnl.2009.3.2.81] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 95 |
Kusunoki H, Kusaka M, Kido S, Yamauchi R, Fujimura Y, Watanabe Y, Kobori M, Miwa H, Tomita T, Kin Y, Hori K, Tano N, Sugimoto K, Nakamura Y, Fujimoto K, Oza N, Matsunobu A, Ono N, Fuyuno S, Kinoshita Y, Adachi K, Yuki M, Fujisawa T, Haruma K. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis. J Gastroenterol 2009;44:261-70. [PMID: 19280112 DOI: 10.1007/s00535-009-0003-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 96 |
Murakami K, Okimoto T, Kodama M, Tanahashi J, Yasaka S, Inoue K, Uchida M, Anan J, Mizukami K, Abe T, Watada M, Fujioka T. Helicobacter pylori and NSAID-induced gastric ulcer in a Japanese population. J Gastroenterol 2009;44 Suppl 19:40-3. [PMID: 19148792 DOI: 10.1007/s00535-008-2259-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 97 |
Saito Y, Suzuki H, Hibi T. The role of microRNAs in gastrointestinal cancers. J Gastroenterol 2009;44 Suppl 19:18-22. [PMID: 19148788 DOI: 10.1007/s00535-008-2285-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 98 |
Ohno T, Sugimoto M, Nagashima A, Ogiwara H, Vilaichone RK, Mahachai V, Graham DY, Yamaoka Y. Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populations. J Gastroenterol Hepatol 2009;24:462-8. [PMID: 19226380 DOI: 10.1111/j.1440-1746.2008.05762.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 99 |
Nishizawa T, Suzuki H, Hibi T. Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication. J Clin Biochem Nutr. 2009;44:119-124. [PMID: 19308265 DOI: 10.3164/jcbn.08-220r] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 100 |
Morishita S, Nishimori I, Minakuchi T, Onishi S, Takeuchi H, Sugiura T, Vullo D, Scozzafava A, Supuran CT. Cloning, polymorphism, and inhibition of beta-carbonic anhydrase of Helicobacter pylori. J Gastroenterol 2008;43:849-57. [PMID: 19012038 DOI: 10.1007/s00535-008-2240-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 101 |
Suzuki H, Nishizawa T, Muraoka H, Hibi T. Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation. Antimicrob Agents Chemother. 2009;53:1720-1721. [PMID: 19188389 DOI: 10.1128/aac.00049-09] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 102 |
Shiozawa E, Norose T, Kaneko K, Yamochi-Onizuka T, Takimoto M, Imawari M, Ota H. Clinicopathological comparison of the World Health Organization/Wotherspoon score to the Groupe d'Etude des Lymphomes de l'Adult grade for the post-treatment evaluation of gastric mucosa-associated lymphoid tissue lymphoma. J Gastroenterol Hepatol 2009;24:307-15. [PMID: 19032451 DOI: 10.1111/j.1440-1746.2008.05639.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 103 |
Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, Wakai K, Tajima K, Hamajima N. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobacter 2009;14:47-53. [PMID: 19191896 DOI: 10.1111/j.1523-5378.2009.00659.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 104 |
Harshaw C. Alimentary Epigenetics: A Developmental Psychobiological Systems View of the Perception of Hunger, Thirst and Satiety. Dev Rev 2008;28:541-69. [PMID: 19956358 DOI: 10.1016/j.dr.2008.08.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 105 |
Nishizawa T, Suzuki H, Nakagawa I, Iwasaki E, Masaoka T, Hibi T. Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication. J Gastroenterol Hepatol 2008;23 Suppl 2:S167-70. [PMID: 19120892 DOI: 10.1111/j.1440-1746.2008.05407.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 106 |
Tajima A, Koizumi K, Suzuki K, Higashi N, Takahashi M, Shimada T, Terano A, Hiraishi H, Kuwayama H. Proton pump inhibitors and recurrent bleeding in peptic ulcer disease. J Gastroenterol Hepatol 2008;23 Suppl 2:S237-41. [PMID: 19120905 DOI: 10.1111/j.1440-1746.2008.05557.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 107 |
Jang EJ, Park SW, Park JS, Park SJ, Hahm KB, Paik SY, Sin MK, Lee ES, Oh SW, Park CY, Baik HW. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J Gastroenterol Hepatol 2008;23 Suppl 2:S278-85. [PMID: 19120912 DOI: 10.1111/j.1440-1746.2008.05415.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 54] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 108 |
Naito Y, Takagi T, Okada H, Nukigi Y, Uchiyama K, Kuroda M, Handa O, Kokura S, Yagi N, Kato Y, Osawa T, Yoshikawa T. Expression of inducible nitric oxide synthase and nitric oxide-modified proteins in Helicobacter pylori-associated atrophic gastric mucosa. J Gastroenterol Hepatol 2008;23 Suppl 2:S250-7. [PMID: 19120907 DOI: 10.1111/j.1440-1746.2008.05412.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 109 |
Tsugawa H, Suzuki H, Nakagawa I, Nishizawa T, Saito Y, Suematsu M, Hibi T. Alpha-ketoglutarate oxidoreductase, an essential salvage enzyme of energy metabolism, in coccoid form of Helicobacter pylori. Biochemical and Biophysical Research Communications 2008;376:46-51. [DOI: 10.1016/j.bbrc.2008.08.078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 110 |
Asahi A, Nishimoto T, Okazaki Y, Suzuki H, Masaoka T, Kawakami Y, Ikeda Y, Kuwana M. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest. 2008;118:2939-2949. [PMID: 18654664 DOI: 10.1172/jci34496] [Cited by in Crossref: 17] [Cited by in F6Publishing: 44] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 111 |
Ye J, Lee JW, Presley LL, Bent E, Wei B, Braun J, Schiller NL, Straus DS, Borneman J. Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice. Inflamm Bowel Dis 2008;14:1041-50. [PMID: 18381614 DOI: 10.1002/ibd.20442] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 112 |
Futagami S, Hiratsuka T, Shindo T, Horie A, Hamamoto T, Suzuki K, Kusunoki M, Miyake K, Gudis K, Crowe SE, Tsukui T, Sakamoto C. Expression of apurinic/apyrimidinic endonuclease-1 (APE-1) in H. pylori-associated gastritis, gastric adenoma, and gastric cancer. Helicobacter 2008;13:209-18. [PMID: 18466396 DOI: 10.1111/j.1523-5378.2008.00605.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 113 |
Nishizawa T, Suzuki H, Masaoka T, Iwasaki E, Hibi T. A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori. Digestion 2007;76:215-20. [PMID: 18174683 DOI: 10.1159/000112649] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 114 |
Shiotani A, Kamada T, Haruma K. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol 2008;43:581-588. [DOI: 10.1007/s00535-008-2206-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 115 |
Minegishi Y, Suzuki H, Arakawa M, Fukushima Y, Masaoka T, Ishikawa T, Wright NA, Hibi T. Reduced Shh expression in TFF2-overexpressing lesions of the gastric fundus under hypochlorhydric conditions. J Pathol 2007;213:161-9. [PMID: 17763396 DOI: 10.1002/path.2221] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 116 |
Lv FJ, Luo XL, Meng X, Jin R, Ding HG, Zhang ST. A low prevalence of H pylori and endoscopic findings in HIV-positive Chinese patients with gastrointestinal symptoms. World J Gastroenterol 2007; 13(41): 5492-5496 [PMID: 17907294 DOI: 10.3748/wjg.v13.i41.5492] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 117 |
Lehours P, Yilmaz O. Epidemiology of Helicobacter pylori infection. Helicobacter 2007;12 Suppl 1:1-3. [PMID: 17727452 DOI: 10.1111/j.1523-5378.2007.00541.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 3.6] [Reference Citation Analysis]
|
